TickerFactsScreenerDevelopers

Anixa Biosciences Inc (ANIX) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2010: -$2.41M2011: -$716.0K2012: -$3.14M2013: -$3.19M2014: -$2.38M2015: $1.36M2016: -$3.38M2017: -$3.80M2018: -$4.27M2019: -$4.74M2020: -$6.18M2021: -$4.94M2022: -$6.49M2023: -$6.21M2024: -$7.33M2025: -$7.17M-$7.17M
2010Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$7.17M+2.2%
2024-$7.33M-18.1%
2023-$6.21M+4.4%
2022-$6.49M-31.5%
2021-$4.94M+20.0%
2020-$6.18M-30.2%
2019-$4.74M-11.0%
2018-$4.27M-12.6%
2017-$3.80M-12.3%
2016-$3.38M-348.0%
2015$1.36M+157.3%
2014-$2.38M+25.3%
2013-$3.19M-1.5%
2012-$3.14M-338.7%
2011-$716.0K+70.2%
2010-$2.41M—